Skip to main content

Day: June 10, 2021

Ocean Biomedical, Inc. Files Registration Statement For Proposed Initial Public Offering

PROVIDENCE, R.I., June 10, 2021 (GLOBE NEWSWIRE) — Ocean Biomedical, Inc. (“Ocean”) today announced that it has publicly filed a Registration Statement on Form S-1 (the “Registration Statement”) with the Securities and Exchange Commission (the “SEC”) relating to a proposed initial public offering of shares of its common stock. Ocean intends to list its common stock on the Nasdaq Global Market under the symbol “OCEA.” The size of the proposed offering and price range for the proposed offering have not yet been determined. It is expected that the net proceeds from Ocean’s initial public offering will be used to fund the clinical development and preclinical development of Ocean’s assets, and for business development activities, working capital and other general corporate purposes. Berenberg and Oppenheimer & Co. are acting as...

Continue reading

MamaMancini’s to Host First Quarter 2022 Earnings Call on Monday, June 14th at 4:30 p.m. Eastern Time

EAST RUTHERFORD, N.J, June 10, 2021 (GLOBE NEWSWIRE) — MamaMancini’s Holdings, Inc. (OTCQB: MMMB), a marketer of specialty pre-prepared, frozen and refrigerated food products, will release financial results for the first quarter of the fiscal year ended January 31, 2022, after market close on Monday, June 14, 2021. Management will host an investor conference call at 4:30 p.m. Eastern time on Monday, June 14, 2021 to discuss the Company’s first quarter 2022 financial results, provide a corporate update, and conclude with a Q&A from participants. To participate, please use the following information: Q1 2022 Earnings Conference Call Date: Monday, June 14, 2021Time: 4:30 p.m. Eastern time U.S. Dial-in: 1-844-889-4326International Dial-in: 1-412-317-9264Conference ID: 10157488Webcast: https://services.choruscall.com/mediaframe/webcast.html?webcastid=ZPxfU8Fd...

Continue reading

Solving Cybersecurity Business Challenges – How to Reduce Risk of Ransomware and Breaches

High Wire Networks’ Overwatch Managed Security Invites Business Executives to a June 16th Virtual Conference: The Future of Managed Cybersecurity is Now BOCA RATON, Fla, June 10, 2021 (GLOBE NEWSWIRE) — Spectrum Global Solutions Inc (the “Company” or “Spectrum”) (OTCQB: SGSI), announced today that High Wire Networks Inc. (“High Wire”) and its cybersecurity business unit, Overwatch Managed Security, are hosting a half-day virtual cybersecurity conference, June 16 from 11 am-3:30 pm ET, to discuss how to reduce risk without breaking your budget. U.S. business and organizations have seen an uptick in ransomware attacks. In just the past month cyber criminals have threatened the nation’s fuel and meat supply, and school systems, hospitals and local governments have suffered increasingly frequent ransomware attacks. “Cybersecurity...

Continue reading

Golden Triangle Ventures, Inc. Announces the Acquisition of Sonder Fulfillment, LLC

LAS VEGAS, June 10, 2021 (GLOBE NEWSWIRE) — via InvestorWire — Golden Triangle Ventures, Inc. (OTC PINK: GTVH) is pleased to announce the full acquisition of Sonder Fulfillment, LLC. Dedicated to driving forward the most powerful and efficacious cannabinoid products in the world, Sonder Fulfillment (the “Company”) is a leading Company in the industrial hemp and CBD industry. Sonder Fulfillment has put together a powerful team of research Ph.Ds, formulary scientists, and flavor compounding specialists to build advanced cannabinoid-based nutritional and homeopathic products that are designed to catalyze the endocannabinoid system (ECS) to support targeted wellness and relief. The Company’s management team has built many well-known products in the natural medicine space for several decades and has coalesced that knowledge to...

Continue reading

IBC Advanced Alloys Announces Increase in Non-Brokered Private Placement to C$1,900,000

[NOT FOR DISTRIBUTION TO U.S. NEWSWIRES OR FOR DISSEMINATION IN THE UNITED STATES] FRANKLIN, Ind., June 10, 2021 (GLOBE NEWSWIRE) — IBC Advanced Alloys Corp. (“IBC” or the “Company”) (TSX-V: IB; OTCQB: IAALF) announces that, further to the Company’s press release dated June 1, 2021, the Company’s non-brokered private placement has been increased to a maximum of up to 9,500,000 units of the Company (the “Units“) at a price of C$0.20 per Unit (the “Issue Price“) for gross proceeds to the Company of up to C$1,900,000 (the “Offering“). There is no minimum offering amount. Each Unit will consist of one common share of IBC (each, a “Common Share“) and one common share purchase warrant (a “Warrant“). Each Warrant will entitle the holder to acquire one common share of the Company...

Continue reading

Atos launches ‘Engaged Employee Experience’ to support organizations tackle the new frontier of work

Press Release Atos launches ‘Engaged Employee Experience’ to support organizations tackle the new frontier of work Paris, France, June 10 2021 – Atos today launches Engaged Employee Experience, a unique initiative which reinforces Atos’ position as a leading enabler in the new frontier of work. Leveraging Atos’ recognized expertise in Digital Workplace Services1, Engaged Employee Experience encompasses the latest tools and technologies, consulting capabilities, and new and existing partnerships with leading experts in the field, all underpinned by clear decarbonization objectives. It is the most comprehensive intersectional set of services on the market today and the only one which combines both traditional Digital Workplace solutions with Employee Experience services. According to Forrester2 “C-level leaders know they are...

Continue reading

Acer Therapeutics Plans Clinical Trial for EDSIVO™ (celiprolol) Following Type B FDA Meeting

Phase 3, randomized, double-blind, placebo-controlled, decentralized clinical trial estimated to take approximately 3.5 years to complete once fully enrolled FDA indicates agreement with submission of proposed protocol under a Special Protocol Assessment (SPA) with possible breakthrough designation NEWTON, Mass., June 10, 2021 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, today announced that following a recent Type B meeting with the U.S. Food and Drug Administration (FDA) regarding Acer’s proposed EDSIVO™ (celiprolol) development plan, the company is now planning a pivotal clinical trial in patients with COL3A1+ vascular Ehlers-Danlos...

Continue reading

Loop Media, Inc. Completes Transaction with Ithaca Holdings, LLC for the Acquisition of EON Media Group Pte. Ltd. and its Asia Pop40 Syndicated Radio Network

Glendale, CA, June 10, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Loop Media, Inc. (“Loop Media”)(OTC: LPTV), a leading provider of its own branded music video and entertainment streaming services for businesses and consumers, today announced that it has completed the acquisition of EON Media Group Pte. Ltd. (“EON Media Group”), in a transaction with Ithaca Holdings, LLC (“Ithaca”). Ithaca is a part of the HYBE America portfolio, a wholly owned subsidiary of HYBE, a South Korean entertainment lifestyle platform company, led by SB Projects’ and HYBE board member Scott “Scooter” Braun. EON Media Group is based in Singapore and is led by founder and CEO, Robert Graham. Loop Media previously purchased a 20% equity interest in EON Media Group for cash and shares of Loop Media common stock in a transaction that closed in December...

Continue reading

Five Below Raises More Than $1.7 Million For Alex’s Lemonade Stand Foundation In 2021

Both organizations celebrate an unprecedented year of partnership success PHILADELPHIA, PA, June 10, 2021 (GLOBE NEWSWIRE) — Five Below, Inc. (NASDAQ: FIVE), the trend-right, extreme-value brand for tweens, teens and beyond, has exceeded its latest fundraising goal as part of its ongoing partnership with Alex’s Lemonade Stand Foundation, raising more than $1.7 million to help support research to find a cure for childhood cancers. Since initially partnering with Alex’s Lemonade Stand Foundation in 2006, Five Below has raised more than $8 million in support of the organization’s crucial mission. “Helping to support such an incredible foundation is extremely important to us and is indicative of everything Five Below stands for as a company,” said George Hill, Executive Vice President of Retail Operations of Five Below. “Every cent...

Continue reading

Veru Enrolls First Patient in Phase 2 Clinical Trial of VERU-100, Novel Long-acting GnRH Antagonist Decapeptide Injection Formulation, for the Treatment of Hormone Sensitive Advanced Prostate Cancer

–VERU-100 formulated to address the clinical limitations of currently available androgen deprivation therapy– –The Phase 2 clinical trial is expected to be completed by 2H calendar 2021– MIAMI, June 10, 2021 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), an oncology biopharmaceutical company with a focus on developing novel medicines for the management of prostate and breast cancer, today announced that it has enrolled the first patient in its Phase 2 clinical trial of VERU-100, a novel, proprietary gonadotropin-releasing hormone (GnRH) antagonist decapeptide, three-month subcutaneous depot injection formulation, for the treatment of hormone sensitive advanced prostate cancer. Androgen deprivation therapy, also known as ADT, is currently the mainstay of advanced prostate cancer treatment and is used as a foundation...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.